Partnering to Advance Critical Care Worldwide

 At Piramal Critical Care, saving and improving patients’ lives is more than a mission — it’s the foundation of everything we do. As a global leader in critical care solutions, our growth has been shaped by a deep commitment to strategic partnerships.

Over the past two decades, we’ve cultivated a diverse portfolio of successful collaborations with pharmaceutical companies across geographies and therapeutic areas such as anesthesia, CNS, and pain management. These partnerships have played a vital role in expanding access to life-saving treatments around the world.

Our journey has been fueled by strategic acquisitions, positioning us today as the third-largest player in the inhaled anesthesia market. Looking ahead, we’re focused on broadening our global footprint through targeted expansion in generic hospital injectables and other niche therapeutic segments.

The Business Development team at Piramal Critical Care leads the identification and evaluation of new opportunities — including co-development, licensing, acquisitions, ANDA and NDA purchases, co-marketing, and promotional alliances. We seek partnerships that align with our strategy of leveraging deep expertise to deliver impactful solutions.

We welcome collaboration opportunities in critical care — to contact or connect with our Business Development team to explore how we can create meaningful impact together please email us at  PCC.BD@Piramal.com.